UArizona awarded $7.3 million grant to study long COVID-19 impact Dec. 5, 2022 UArizona Health Sciences researchers received $7.3 million in funding from the Centers for Disease Control and Prevention to participate in “Tracking the Burden, Distribution, Impact of Post COVID-19 Conditions in Diverse Populations for Children, Adolescents, Adults,” or Track PCC. KPHO-TV (Phoenix, AZ)
Arizona sees an increase in COVID-19 hospitalizations, among highest in the nation Dec. 5, 2022 Arizona has been leading the nation with COVID-19 cases for weeks now, and with the holidays approaching, doctors expect these numbers to rise. KPHO-TV (Phoenix, AZ)
It’s not too late to apply to BS/MD programs: 26 programs with late deadlines Dec. 3, 2022 The College of Medicine – Tucson's Accelerated Pathway to Medical Education is one of 26 programs listed that has a later application deadline. Forbes
Research and Health Care Technologies Focus of HealthTech Connect Event Dec. 2, 2022 Join HealthTech Connect in Phoenix on Dec. 15 for a half-day program devoted to advances in health technologies. Read more Image
Women missing out on opportunities from advisory boards Dec. 2, 2022 A study published in the Journal of Clinical Oncology found that on 15 advisory boards that were composed between 2019 and 2022, 106 (71%) advisory board members were men and only 43 (29%) were women. Medscape
Current rural health care environment 'not sustainable' Dec. 1, 2022 An article about rural health care cites information presented at an Arizona Telemedicine Program webinar in November. Chronicle Media
Signs you may have diabetes and when to seek help Dec. 1, 2022 According to the CDC, more than 37 million adults are living with diabetes and 1 in 5 have no idea. Yahoo Life
Arizona is the only state that has medium/high COVID-19 levels in all its counties Dec. 1, 2022 Eight Arizona counties currently have high COVID-19 transmission levels, and Arizona is the only state in the country where every single county has medium or high levels of transmission. KPHO-TV (Phoenix, AZ)
Dr. Ivo Abraham column: 1 billion people can access biosimilars; what about the other 7 billion? Dec. 1, 2022 Ivo Abraham, PhD, professor of practice in the R. Ken Coit College of Pharmacy, examines how high-income countries can increase accessibility to lifesaving medicines to the 7 billion people who have limited access to biosimilars. Center for Biosimilars